Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2000
10/31/2000US6140342 Cholesteryl ester transfer protein inhibitor; used to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as ldl-cholesterol and triglycerides
10/31/2000US6140337 Methods for the treatment of mental disorders
10/31/2000US6140327 Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor
10/31/2000US6140067 Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus
10/31/2000US6139872 Method of producing a vitamin product
10/31/2000US6138679 Method suitable for influencing the ingestion of food by humans via the mouth cavity
10/31/2000CA2116535C A method for treatment of patients with chronic liver disease
10/30/2000CA2306502A1 Process for preparing spray granules containing riboflavin
10/26/2000WO2000063702A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000WO2000063430A1 Diagnosis of a person's risk for developing atherosclerosis or diabetic retinopathy
10/26/2000WO2000063415A1 Dna encoding the human vanilloid receptor vr1
10/26/2000WO2000063393A1 Dsp-8 dual-specificity map kinase phosphatase
10/26/2000WO2000063374A1 Synthetic transmembrane components
10/26/2000WO2000063372A1 Synthetic signalling molecules
10/26/2000WO2000063370A2 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000WO2000063361A2 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides
10/26/2000WO2000063351A2 Carbohydrate-modifying enzymes
10/26/2000WO2000063251A1 Composition and method for modulating dendritic cell-t cell interaction
10/26/2000WO2000063209A1 New compounds, their preparation and use
10/26/2000WO2000063208A1 Substituted imidazoles, their preparation and use
10/26/2000WO2000063206A2 Thiazolidinedione derivative and its use as antidiabetic
10/26/2000WO2000063205A2 Thiazolidinedione derivative and its use as antidiabetic
10/26/2000WO2000063204A2 Substituted azoles
10/26/2000WO2000063196A1 New compounds, their preparation and use
10/26/2000WO2000063193A1 Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
10/26/2000WO2000063191A1 Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
10/26/2000WO2000063190A1 New compounds, their preparation and use
10/26/2000WO2000063189A1 Crystalline r- guanidines, arginine or (l) -arginine (2s) -2- ethoxy -3-{4- [2-(10h -phenoxazin -10-yl)ethoxy]phenyl}propanoate
10/26/2000WO2000063181A1 Use of maduraphthalazine derivatives as inhibitors of pro-inflammatory cytokins
10/26/2000WO2000063178A1 Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosis
10/26/2000WO2000063170A1 Cyclobutene-3,4-dione derivatives as inhibitors of phosphodiesterase 5
10/26/2000WO2000063161A1 Ppar-(gamma) agonists as agents for the treatment of type ii diabetes
10/26/2000WO2000063160A1 2-alkoxy-cyclobutene-3,4-dione derivatives, preparation and therapeutic use thereof
10/26/2000WO2000063153A1 New compounds, their preparation and use
10/26/2000WO2000062862A1 Method of prophylaxis and treatment of diabetes
10/26/2000WO2000062810A1 An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport
10/26/2000WO2000062797A1 Remedies for autonomic neuropathy
10/26/2000WO2000062796A1 Agents for ameliorating pancreatic function disorder
10/26/2000WO2000062791A1 D-form polypeptide which induces immune tolerance and methods of use
10/26/2000WO2000062781A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk
10/26/2000WO2000062780A1 Use of glucosylceramide synthesis inhibitors in therapy
10/26/2000WO2000062779A1 Combination of glucosylceramide synthesis inhibitors and glycolipid degrading enzyme in therapy
10/26/2000WO2000062774A1 Methods of treating clinical diseases with isoflavones
10/26/2000WO2000062770A1 Compounds useful as phosphotyrosine mimics
10/26/2000WO2000062767A2 Pharmaceutical compositions containing pyridine or pyrimidine derivates for inhibition of cytokine production and secretion
10/26/2000WO2000062766A2 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/26/2000WO2000062631A1 Cacao extract including dietary fiber
10/26/2000WO2000062605A1 eNOS MUTATIONS USEFUL FOR GENE THERAPY AND THERAPEUTIC SCREENING
10/26/2000WO2000039275A3 Multiple shear stress responsive elements (ssre) and methods of use thereof
10/26/2000WO2000039120A3 Compounds and methods for modulation of estrogen receptors
10/26/2000WO2000038698A3 Substances from porcine tissue
10/26/2000WO2000031120A3 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
10/26/2000WO2000023603A8 Methods of treatment of type 2 diabetes
10/26/2000WO2000017191A3 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
10/26/2000WO2000017190A3 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
10/26/2000DE19918211A1 New 2-carbocyclyl-benzimidazole-carboxamide derivatives, are PARP inhibitors useful e.g. for treating neurodegenerative disease, epilepsy, ischemia, tumors, inflammation or diabetes
10/26/2000CA2758956A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000CA2382036A1 Novel pharmaceutical
10/26/2000CA2379105A1 An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport
10/26/2000CA2373359A1 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000CA2370742A1 Ppar-(gamma) agonists as agents for the treatment of type ii diabetes
10/26/2000CA2370617A1 Dsp-8 dual-specificity map kinase phosphatase
10/26/2000CA2370570A1 Dna encoding the human vanilloid receptor vr1
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2370270A1 Novel pharmaceutical
10/26/2000CA2370127A1 Novel method of treatment
10/26/2000CA2369764A1 Enos mutations useful for gene therapy and therapeutic screening
10/26/2000CA2369633A1 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides
10/26/2000CA2369342A1 Carbohydrate-modifying enzymes
10/26/2000CA2369078A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk
10/26/2000CA2368839A1 D-form polypeptide which induces immune tolerance and methods of use
10/26/2000CA2368784A1 Methods of treating clinical diseases with isoflavones
10/26/2000CA2367359A1 Dibenzoazulene derivatives for the treatment of thrombosis, osteoporosis, arteriosclerosis
10/26/2000CA2367356A1 New compounds, their preparation and use
10/26/2000CA2363994A1 Diagnosis of a person's risk for developing atherosclerosis or diabetic retinopathy
10/26/2000CA2363689A1 Compounds useful as phosphotyrosine mimics
10/26/2000CA2330231A1 Composition and method for modulating dendritic cell-t cell interaction
10/25/2000EP1046652A1 Method for quantitating denatured ldls
10/25/2000EP1046651A1 Composition and method for modulating dendritic cell-T interaction
10/25/2000EP1046410A2 Calcium and magnesium containing phosphate binding agent for the treatment of hyperphosphatemia
10/25/2000EP1046396A2 Soy protein and plant sterol containing composition for the reduction of low density lipoprotein cholesterol concentration
10/25/2000EP1046345A2 Preparation for administration to animals and feeding method thereof
10/25/2000EP1045936A1 Aqueous compositions comprising complexing agents and uses therof
10/25/2000EP1045847A1 Hydrate of 5- 4- 2- (n-methyl-n- (2-pyridil)amino) ethoxy]benzyl] thiazolidine-2, 4-dione maleic acid salt
10/25/2000EP1045845A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
10/25/2000EP1045840A1 Hypolipidemic benzothiazepine compounds
10/25/2000EP1045836A1 Pyridones as src family sh2 domain inhibitors
10/25/2000EP1045832A2 Novel urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof
10/25/2000EP1045701A1 Methods of using human receptor protein 4-1bb
10/25/2000EP1045696A1 Oral oil sorbing composition
10/25/2000EP1045691A1 Statin-carboxyalkylether combinations
10/25/2000EP0750626B1 Corpuscles of stannius protein, stanniocalcin
10/25/2000EP0736039B1 Compounds with growth hormone releasing properties
10/25/2000EP0720601B1 Gastrin and cck receptor ligands
10/25/2000CN1271289A Osteoblast-specific mitogens and drugs containing such compounds
10/25/2000CN1271279A Amide derivatives for the treatment of diseases mediated by cytokines
10/25/2000CN1270830A Sanjiangcha tea for reducing blood sugar, blood pressure and blood lipoid and its preparation
10/25/2000CN1057768C Sterol compositions from pulping soap
10/25/2000CN1057760C Amino acid substituted benzoylguanidines, process for their preparation, their use and medicament containing them
10/24/2000US6136974 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments
1 ... 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 ... 1298